BRCA1 and ovarian carcinoma: The alteration reported here has not been detected in any of the other 244 BRCA1/2-negative patients with a family history of breast and ovarian cancer analysed with MLPA in our laboratory, suggesting that this duplication is a rare variant and it is conceivable that it could contribute in an appreciable manner to cancer development.